The PE Ratio as of December 2025 (TTM) for Hester Biosciences Limited (HESTERBIO.NS) is 31.15

According to Hester Biosciences Limited’s latest financial reports and current stock price. The company's current PE Ratio is 31.15. This represents a change of -58.54% compared to the average of 75.13 of the last 4 quarters.

Hester Biosciences Limited (HESTERBIO.NS) Historical PE Ratio (quarterly & annually)

How has HESTERBIO.NS PE Ratio performed in the past?

The mean historical PE Ratio of Hester Biosciences Limited over the last ten years is 42.57. The current 31.15 PE Ratio has changed 7.22% with respect to the historical average. Over the past ten years (40 quarters), HESTERBIO.NS's PE Ratio was at its highest in in the March 2025 quarter at 204.51. The PE Ratio was at its lowest in in the June 2015 quarter at 0.

Hester Biosciences Limited (HESTERBIO.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hester Biosciences Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hester Biosciences Limited (HESTERBIO.NS) Average PE Ratio

How has HESTERBIO.NS PE Ratio performed in the past?

The current PE Ratio of Hester Biosciences Limited (HESTERBIO.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hester Biosciences Limited (HESTERBIO.NS) PE Ratio vs. Peers

How is HESTERBIO.NS’s PE Ratio compared to its peers?

Hester Biosciences Limited’s PE Ratio is greater than Bajaj HealthCare Limited (28.84), greater than Bajaj HealthCare Limited (28.84), greater than Jagsonpal Pharmaceuticals Limited (21.66), greater than Sigachi Industries Limited (-23.73), greater than Sigachi Industries Limited (-23.73), greater than Jagsonpal Pharmaceuticals Limited (21.66), greater than Syncom Formulations (India) Limited (21.14), greater than Syncom Formulations (India) Limited (21.14), greater than Bliss GVS Pharma Limited (16.66), greater than Bliss GVS Pharma Limited (16.66),

Build a custom stock screener for Hester Biosciences Limited (HESTERBIO.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hester Biosciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hester Biosciences Limited (HESTERBIO.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hester Biosciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.